JNJ Logo

Johnson & Johnson (JNJ) 

NYSE
Market Cap
$381.11B
Sector
Healthcare
Industry
Drug Manufacturers—General
Rank in Sector
367 of 776
Rank in Industry
5 of 10

Largest Insider Buys in Sector

JNJ Stock Price History Chart

JNJ Stock Performance

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; …

Insider Activity of Johnson & Johnson

Over the last 12 months, insiders at Johnson & Johnson have bought $0 and sold $11.65M worth of Johnson & Johnson stock.

On average, over the past 5 years, insiders at Johnson & Johnson have bought $1.54M and sold $36.89M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $127,686 was made by PEREZ WILLIAM D (director) on 2020‑03‑13.

List of Insider Buy and Sell Transactions, Johnson & Johnson

2024-08-30SaleVP Corporate Controller
5,635
0.0002%
$165.06$930,113-1.71%
2024-03-13SaleEVP, Global Corp Affairs
8,891
0.0004%
$162.16$1.44M-3.31%
2024-02-09SaleEVP, WW Chair, Pharmaceuticals
59,397
0.0024%
$156.27$9.28M+0.72%
2023-07-26SaleSee Remarks
14,698
0.0006%
$172.00$2.53M-9.68%
2023-07-25SaleExec VP, Chief HR Officer
20,000
0.0008%
$170.32$3.41M-9.45%
2023-06-12SaleEVP, Chief TO and Risk Officer
12,465
0.0005%
$160.00$1.99M-1.34%
2023-03-06SaleSee Remarks
1,061.68
<0.0001%
$154.66$164,199+3.00%
2022-12-13SaleExec VP, CFO
14,781
0.0006%
$179.60$2.65M-9.46%
2022-11-30SaleEVP, WW Chair, MedTech
73,323
0.0027%
$175.47$12.87M-8.48%
2022-11-22SaleEVP, WW Chair, Pharmaceuticals
76,923
0.0029%
$176.78$13.6M-7.60%
2022-11-18SaleController, CAO
16,928
0.0006%
$175.00$2.96M-6.62%
2022-11-09SaleEVP, Chief GSC Officer
16,410
0.0006%
$173.42$2.85M-4.34%
2022-11-04SaleExec VP, WW Chair, Consumer
35,246
0.0013%
$171.18$6.03M-3.71%
2022-10-24SaleExec VP, Chief HR Officer
9,064
0.0003%
$171.36$1.55M-2.95%
2022-10-24SaleExec VP, Chief HR Officer
78,458
0.003%
$171.25$13.44M-2.95%
2022-10-24SaleSee Remarks
15,000
0.0006%
$171.55$2.57M-2.95%
2022-10-19SaleExec VP, Chief HR Officer
92,990
0.0035%
$164.50$15.3M+0.97%
2022-10-19SaleExec VP, Chief HR Officer
67,591
0.0026%
$164.50$11.12M+0.97%
2022-06-10SaleEVP, Chief GSC Officer
73,126
0.0028%
$173.00$12.65M-2.88%
2022-05-26SaleController, CAO
16,924
0.0006%
$180.00$3.05M-6.09%

Insider Historical Profitability

3.21%
PRINCE CHARLESdirector
28520
0.0012%
$158.3060+5.17%
PEREZ WILLIAM Ddirector
16030
0.0007%
$158.30140+2.64%
MULCAHY ANNE Mdirector
6537
0.0003%
$158.3010+1.82%
Joly Hubertdirector
5000
0.0002%
$158.3010+5.24%
SATCHER DAVIDdirector
2491
0.0001%
$158.3010+1.72%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$36.22B9.51228.94M-0.2%-$71.05M0.67
BlackRock$30.01B7.88189.73M+1.83%+$540.76M0.65
State Street$21.12B5.55133.52M+0.46%+$97.36M0.86
Geode Capital Management$8.42B2.2253.32M+4.03%+$326.07M0.72
Morgan Stanley$6.73B1.7742.55M+2.14%+$140.86M0.5
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.